Indication: 1. For the treatment of urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. For the treatment of acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae; 3. For the treatment of acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae; 4. For the treatment of intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei; 5. For the treatment of Pneumocystis carinii pneumonia, this product is the first choice; 6. For the prevention of Pneumocystis carinii pneumonia, existing Pneumocystis carinii can be used

Indication: In recent years, many common clinical pathogens are often resistant to this product, so it is necessary to refer to the drug sensitivity results when treating bacterial infections. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii, or H

Indication: In recent years, many common clinical pathogens are often resistant to this product, so it is necessary to refer to the drug sensitivity results when treating bacterial infections. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella. 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae. 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae. 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei. 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia. 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii, or H

Indication: 1. For the treatment of urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. For the treatment of acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae; 3. For the treatment of acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae; 4. For the treatment of intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei; 5. For the treatment of Pneumocystis carinii pneumonia, this product is the first choice; 6. For the prevention of Pneumocystis carinii pneumonia, existing Pneumocystis carinii can be used

Indication: 1. Urinary tract infection caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae; 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae; 4. Intestinal infection and Shigella infection caused by sensitive strains of Shigella flexneri or Shigella sonnei; 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia; 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii or in adults infected with HIV

Indication: 1. Urinary tract infection caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae; 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae; 4. Intestinal infection and Shigella infection caused by sensitive strains of Shigella flexneri or Shigella sonnei; 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia; 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii or in adults infected with HIV

Indication: In recent years, many common clinical pathogens are often resistant to this product, so the treatment of bacterial infections needs to refer to the drug sensitivity results. The main indications of this product are the following infections caused by sensitive strains: 1. Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae; 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae; 4. Intestinal infections and Shigella infections caused by sensitive strains of Shigella flexneri or Shigella sonnei; 5. Treatment of Pneumocystis carinii pneumonia,

Indication: It is suitable for infections caused by microorganisms that are sensitive to clarithromycin: 1. Lower respiratory tract infections: such as bronchitis, pneumonia, etc.; 2. Upper respiratory tract infections: such as pharyngitis, sinusitis, etc.; 3. Mild to moderate infections of the skin and soft tissues: such as folliculitis, cellulitis, erysipelas, etc.